Tripeptide and tetrapeptide sulfones

Details Tripeptide and tetrapeptide sulfones Tripeptide and tetrapeptide sulfones

2007-03-20

2007-03-20

Tsang, Cecilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

11326975

ABSTRACT:
Tripeptide and tetrapeptide sulfones, pharmaceutical compositions containing them, their pharmaceutical use, and their preparation, are disclosed. The compounds are useful in potentiating the cytotoxic effects of chemotherapeutic agents in tumor cells, selectively exerting toxicity in tumor cells, elevating the production of GM progenitors in bone marrow cells, stimulating the differentiation of bone marrow, mitigating the myelosuppressive effects of chemotherapeutic agents, and modulating hematopoiesis in bone marrow.

REFERENCES:
patent: 5556942 (1996-09-01), Kauvar et al.
patent: 5599903 (1997-02-01), Kauvar et al.
patent: 5763570 (1998-06-01), Kauvar et al.
patent: 5767086 (1998-06-01), Kauvar et al.
patent: 5786336 (1998-07-01), Kauvar et al.
patent: 5955432 (1999-09-01), Kauvar et al.
patent: 6627732 (2003-09-01), Sakon et al.
patent: 7029695 (2006-04-01), Redelmeier et al.
patent: 7129215 (2006-10-01), Aurrecoechea et al.
patent: 2003/0100511 (2003-05-01), Kauvar et al.
patent: 0645397 (1998-09-01), None
patent: WO 95/08563 (1995-03-01), None
patent: WO 95/09865 (1995-04-01), None
patent: WO 95/09866 (1995-04-01), None
patent: WO 96/40205 (1996-12-01), None
patent: WO 98/09986 (1998-03-01), None
patent: WO 99/54346 (1999-10-01), None
patent: WO 00/44366 (2000-08-01), None
Lyttle et al. “Isozyme-Specific Glutathione-S-Transferase Inhibitors: Design and Synthesis” J. Med. Chem., 1994, 37, 189-94.
Johansson et al. “The Human Glutathione Transferase P1-1 Specific Inhibitor TER 117 Designed for Overcoming Cytostatic-Drug Resistance is also a Strong Inhibitor of Glyoxalase I” Mol. Pharm., 2000, 57, 619-24.
Lyttle et al. “Glutathione-S-Transferase Activates Novel Alkylating Agents” J. Med. Chem., 1994, 37, 1501-7.
U.S. Appl. No. 11/325,846, filed Jan. 4, 2006, Aurrecoechea et al.
Townsend et al. Efficacy of a Glutathions S- Transferase π-activated Prodrug in Platinum-resistant Ovarian Cancer Cells:Molecular Cancer Therapeutics. (Oct. 2002) 1:1089-1095.
Ciaccio et al., “Modulation of detoxification gene expression in human colon HT29 cells by glutathione S-transferase inhibitors”, Mol. Pharmacol., 48(4), 639-647 (1995).
Hamilton & Batist, “TLK-199”, Drugs, 8(8), 662-669 (2005).
Shiotsuki et al., “Inhibition of glutathione transferase by S-benzyl glutathione analogous to the conjugate of saligenin cyclic phosphate”, Pestic. Biochem. Physiol., 37(2), 121-129 (1990).
Vince et al., “Studies on the inhibition of glyoxalase I by S-substituted glutathiones”, J. Med. Chem., 14(5), 402-404 (1971).

Affiliated with

Also associated with

Rating

Tripeptide and tetrapeptide sulfones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tripeptide and tetrapeptide sulfones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tripeptide and tetrapeptide sulfones will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3776365